NAFLD Presents Similar Risk for Adverse Outcomes Regardless of BMI
Patients with lean NAFLD had fewer metabolic comorbidities but maintained similar risk of NASH, cirrhosis, nonliver cancer, and mortality compared to their overweight and obese counterparts.
Source: hcplive.com